Lou Basenese, Director at ENDRA Life Sciences Inc. (NDRA), bought 10,000 shares at $0.71 ($7K) on 2020-05-21, disclosed to the SEC on 2020-05-22.
Open-market purchase of $7k NDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NDRA | BUY | 2020-05-29 | $9K | — | Filing → |
| NDRA | BUY | 2020-05-28 | $9K | — | Filing → |
| NDRA | BUY | 2020-05-27 | $8K | — | Filing → |